Literature DB >> 20861345

Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and Etest methods.

Rodrigo M Paiva1, Alice B Mombach Pinheiro Machado, Alexandre P Zavascki, Afonso L Barth.   

Abstract

Vancomycin MIC results were determined by the broth microdilution (BMD) method and by Etest using 130 methicillin-resistant coagulase-negative staphylococcus bloodstream isolates obtained from a tertiary hospital. The majority (98.5%) of MIC results determined by BMD were ≤1 μg/ml, in contrast to MIC results determined by Etest (72.3% were ≥1.5 μg/ml). The MICs obtained by Etest were, in general, 1- to 2-fold higher than the MICs obtained by BMD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861345      PMCID: PMC3008465          DOI: 10.1128/JCM.01182-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D J Diekema; M A Pfaller; F J Schmitz; J Smayevsky; J Bell; R N Jones; M Beach
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

2.  Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.

Authors:  E Tacconelli; M Tumbarello; K G Donati; M Bettio; T Spanu; F Leone; L A Sechi; S Zanetti; G Fadda; R Cauda
Journal:  Clin Infect Dis       Date:  2001-10-05       Impact factor: 9.079

3.  Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).

Authors:  Ana C Gales; Helio S Sader; Julival Ribeiro; Cassia Zoccoli; Afonso Barth; Antonio C Pignatari
Journal:  Braz J Infect Dis       Date:  2009-04       Impact factor: 1.949

4.  Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.

Authors:  Russell Hope; David M Livermore; Geraldine Brick; Mark Lillie; Rosy Reynolds
Journal:  J Antimicrob Chemother       Date:  2008-11       Impact factor: 5.790

5.  Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.

Authors:  Donald I Hsu; Levita K Hidayat; Ryan Quist; Janet Hindler; Asa Karlsson; Anne Yusof; Annie Wong-Beringer
Journal:  Int J Antimicrob Agents       Date:  2008-08-12       Impact factor: 5.283

6.  Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005.

Authors:  Edward O Mason; Linda B Lamberth; Wendy A Hammerman; Kristina G Hulten; James Versalovic; Sheldon L Kaplan
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

7.  Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.

Authors:  Helio S Sader; Paul R Rhomberg; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

Review 8.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus.

Authors:  Jana M Swenson; Karen F Anderson; David R Lonsway; Angela Thompson; Sigrid K McAllister; Brandi M Limbago; Roberta B Carey; Fred C Tenover; Jean B Patel
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

10.  Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri.

Authors:  Kimberly J Center; Annette C Reboli; Robin Hubler; Gail L Rodgers; Sarah S Long
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

View more
  3 in total

1.  Glycopeptide resistance in gram-positive cocci: a review.

Authors:  S Sujatha; Ira Praharaj
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-06-19

2.  Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?

Authors:  Patrick M Honore; David De Bels; Luc Kugener; Sebastien Redant; Rachid Attou; Andrea Gallerani; Herbert D Spapen
Journal:  Crit Care       Date:  2019-01-17       Impact factor: 9.097

3.  In vitro susceptibility of Propionibacterium acnes to simulated intrawound vancomycin concentrations.

Authors:  Luke W Hosack; Derek J Overstreet; Evan S Lederman
Journal:  JSES Open Access       Date:  2017-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.